Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, et al. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell Rep Med. 2022;3(2):100522.

Kim J-, Yang Y-, Xie J, Lee O, Kim JH, Hong J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022;29(8):1625-1638.

McEachron J, Baqir AW, Zhou N, Jabbar A, Gupta R, Levitan D, et al. Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinoma. Gynecol Oncol Rep. 2022;39:100918.

Makhani SS, Schwartz J, Vasovic LV, DeSimone RA, Kaicker S, Bussel J, et al. Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample. J Clin Apher. 2022;37(5):507-511.

Rivera-Cruz G, Boyraz B, Petrozza JC. How a woman's myomectomy saved her father's life: evidence of fumarate hydratase-deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase. F S Rep. 2022;3(1):26-31.

Stenzl A, Sternberg CN, Ghith J, Serfass L, Schijvenaars BJ, Sboner A. Application of artificial intelligence to overcome clinical information overload in urological cancer. BJU Int. 2022;130(3):291-300.

Cornell C, Khani F, Osunkoya AO, Matoso A, Miyamoto H, Gordetsky JB, et al. Secondary malignancy after urologic reconstruction procedures: a multi-institutional case series. Hum Pathol. 2022;119:69-78.

Moscat J, Cuervo AM, Diaz-Meco MT. Immunosurveillance, interferon, and autophagic networking in cancer: the PRKCI-ULK2 paradigm. Autophagy. 2022;18(1):226-227.

Hernandez-Prera JC, Saeed-Vafa D, Heidarian A, Gewandter K, Otto K, Wenig BM. Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature. Head Neck Pathol. 2022;16(2):416-426.

van der Mijn JC, Chen Q, Laursen KB, Khani F, Wang X, Dorsaint P, et al. Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR). Mol Carcinog. 2022;61(9):851-864.